Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
535 JPY | -0.19% | +1.33% | +7.86% |
Apr. 17 | NAOS Ex-50 Declares Quarterly Dividend | MT |
Apr. 03 | ARS Pharmaceuticals Submits Response to FDA Letter for Neffy | DJ |
Sales 2022 | 54.92B 353M | Sales 2023 | 57.07B 366M | Capitalization | 21.45B 138M |
---|---|---|---|---|---|
Net income 2022 | 1.71B 10.96M | Net income 2023 | 2B 12.85M | EV / Sales 2022 | 0.33 x |
Net cash position 2022 | 3.45B 22.17M | Net cash position 2023 | 3.8B 24.37M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
12.5
x | P/E ratio 2023 |
10.7
x | Employees | 1,591 |
Yield 2022 |
3.99% | Yield 2023 |
4.18% | Free-Float | 29.06% |
1 day | -0.19% | ||
1 week | +1.33% | ||
Current month | +0.56% | ||
1 month | -0.19% | ||
3 months | +0.19% | ||
6 months | +9.63% | ||
Current year | +7.86% |
Managers | Title | Age | Since |
---|---|---|---|
Yuji Ii
DFI | Director of Finance/CFO | - | - |
Kan Yoshimura
PSD | President | 63 | 84-03-31 |
Hiroaki Oshima
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hiroo Shimada
BRD | Director/Board Member | 81 | 15-05-31 |
Kan Yoshimura
PSD | President | 63 | 84-03-31 |
Kenichi Miyajima
BRD | Director/Board Member | 69 | 21-06-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | +5.00% | ||
0.00% | 0 M€ | +15.35% | - | |
0.00% | 0 M€ | +16.52% | - | |
0.00% | 0 M€ | +16.43% | - | |
0.00% | 0 M€ | +15.51% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 535 | -0.19% | 12,300 |
24-05-09 | 536 | -0.56% | 26,800 |
24-05-08 | 539 | 0.00% | 33,900 |
24-05-07 | 539 | +2.08% | 51,000 |
24-05-02 | 528 | -0.75% | 28,800 |
Delayed Quote Japan Exchange, May 10, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+7.86% | 148M | |
-1.32% | 49.39B | |
+14.01% | 24.75B | |
+0.07% | 17.55B | |
+16.16% | 15.12B | |
+23.57% | 13.23B | |
+40.33% | 7.74B | |
+11.88% | 6.95B | |
-1.87% | 6.39B | |
+11.64% | 6.3B |
- Stock Market
- Equities
- 9788 Stock